14-94378528-G-C
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000295.5(SERPINA1):āc.1178C>Gā(p.Pro393Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000274 in 1,461,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P393L) has been classified as Pathogenic.
Frequency
Consequence
NM_000295.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SERPINA1 | NM_000295.5 | c.1178C>G | p.Pro393Arg | missense_variant | 5/5 | ENST00000393087.9 | NP_000286.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SERPINA1 | ENST00000393087.9 | c.1178C>G | p.Pro393Arg | missense_variant | 5/5 | 1 | NM_000295.5 | ENSP00000376802 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251476Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135908
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1461884Hom.: 0 Cov.: 33 AF XY: 0.0000248 AC XY: 18AN XY: 727244
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Alpha-1-antitrypsin deficiency Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 30, 2022 | The p.Pro393Arg variant in SERPINA1 has not been reported in individuals with SERPINA1-related phenotypes including alpha-1 antitrypsin deficiency and was absent from large population studies. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. Two additional variants involving this codon (p.Pro393Leu, p.Pro393Ser) have been identified in individuals with SERPINA1-related phenotypes, suggesting that this codon is intolerant to variation. In summary, although additional studies are required to fully establish its clinical significance, the p.Pro393Arg variant likely pathogenic for autosomal recessive alpha-1 antitrypsin deficiency. ACMG/AMP Criteria applied: PM5_S, PP3, PM2_P. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2022 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Pro393 amino acid residue in SERPINA1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10234508, 18024524, 27296815). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SERPINA1 protein function. ClinVar contains an entry for this variant (Variation ID: 1066793). This variant has not been reported in the literature in individuals affected with SERPINA1-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 393 of the SERPINA1 protein (p.Pro393Arg). - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Apr 05, 2022 | The SERPINA1 c.1178C>G variant is classified as LIKELY PATHOGENIC (PS4, PM5, PP3) The SERPINA1 c.1178C>G variant is a single nucleotide change in exon 5/5 of the SERPINA1 gene, which is predicted to change the amino acid proline at position 393 in the protein to arginine. The variant has been reported in a patient with Alpha-1-antitrypsin deficiency (PS4) and similar missense variants affecting the same residue have also been reported as pathogenic (PMID:27296815, 18024524, 10234508, 27296815), suggesting that this residue is clinically significant (PM5). Computational predictions support a deleterious effect on the gene or gene product (PP3). The variant has been reported in dbSNP (rs199422209) and has been reported as likely pathogenic by other diagnostic laboratories (ClinVar Variation ID: 1066793). It has not been reported in HGMD. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at